System-level study on synergism and antagonism of active ingredients in traditional chinese medicine by using molecular imprinting technology

Scientific Reports

Volumn 4, Issue , 2014, Pages 1-10

  Chen, Tengfei ^a   Gu, Jiangyong ^b   Zhang, Xinzhuang ^c   Ma, Yimin ^c   Cao, Liang ^c   Wang, Zhenzhong ^c   Chen, Lirong ^b   Xu, Xiaojie ^b   Xiao, Wei ^a,c  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b PEKING UNIVERSITY   (China)

^c Institute of Traditional Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CAFFEIC ACID; CAFFEIC ACID DERIVATIVE; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2;

ANIMAL; ARTEMISIA; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CHINESE MEDICINE; CYTOLOGY; DRUG EFFECTS; DRUG POTENTIATION; GARDENIA; ISOLATION AND PURIFICATION; KINETICS; LONICERA; MACROPHAGE; METABOLISM; MOLECULAR IMPRINTING; MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTEMISIA; CAFFEIC ACIDS; CELL LINE; DINOPROSTONE; DRUG SYNERGISM; GARDENIA; KINETICS; LIPOPOLYSACCHARIDES; LONICERA; MACROPHAGES; MEDICINE, CHINESE TRADITIONAL; MICE; MOLECULAR IMPRINTING;

EID: 84947719246     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07159     Document Type: Article

References (50)

1. Auffray, C., Chen, Z. & Hood, L. Systems medicine: the future of medical genomics and healthcare. Genome Med. 1, 2 (2009).
2. Drasar, P. & Moravcova, J. Recent advances in analysis of Chinese medical plants and traditional medicines. J. Chromatogr. B 812, 3-21 (2004).
3. Wang, H., Zou, H., Ni, J. & Guo, B. Comparative separation of biologically active components in Rhizoma chuanxiong by affinity chromatography with alpha(1)-acid glycoprotein and human serum albumin as stationary phases. Chromatographia 52, 459-464 (2000).
4. Zhang, Y. et al. A Novel Analgesic Isolated from a Traditional Chinese Medicine. Curr. Biol. 24, 117-123 (2014).
5. Ma, T. et al. Bridging the gap between traditional Chinese medicine and systems biology: the connection of Cold Syndrome and NEI network. Mol. BioSyst. 6, 613-619 (2010).
6. Gu, J. Y., Chen, L. R., Yuan, G. & Xu, X. J. A Drug-Target Network-Based Approach to Evaluate the Efficacy of Medicinal Plants for Type II Diabetes Mellitus. Evid. Based Complement. Alt. 2013, 203614 (2013).
7. Li, S. & Zhang, B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin. J. Nat. Med. 11, 110-120 (2013).
8. Liu, Y. H., Ming, K. J., Sai, C. L. & Khang, G. N. Synergistic effect of traditional Chinese medicine. Asian J. Chem. 19, 867-882 (2007).
9. Zhao, M., Zhou, Q., Ma, W. & Wei, D. Q. Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods, and applications. Evid. Based Complement. Alt. 2013, 806072 (2013).
10. Shen, M. Y. et al. Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines. J. Cheminform. 4, 31 (2012).
11. Xu, X. J. New concepts and approaches for drug discovery based on traditional Chinese medicine. Drug Discov. Today 3, 247-253 (2006).
12. Li, S., Zhang, B. & Zhang, N. B. Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Syst. Biol. 5, S10 (2011).
13. Wang, L. et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 105, 4826-4831 (2008).
14. Gu, P. Q. & Chen, H. J. Modern bioinformatics meets traditional Chinese medicine. Brief. Bioinform. DOI: 10.1093/bib/bbt063 (2013).
15. Li, J. et al. Synergism and rules from combination of Baicalin, Jasminoidin and Desoxycholic acid in refined Qing Kai Ling for treat ischemic stroke mice model. PLoS One 7, e45811 (2012).
16. Ma, X. H. et al. Synergistic therapeutic actions of herbal ingredients and their mechanisms from molecular interaction and network perspectives. Drug Discov. Today 14, 579-588 (2009).
17. Ulrich-Merzenich, G., Panek, D., Zeitler, H., Vetter, H. & Wagner, H. Drug development from natural products: Exploiting synergistic effects. Indian J. Exp. Biol. 48, 208-219 (2010).
18. Alexander, C. et al. Molecular imprinting science and technology: a survey of the literature for the years up to and including 2003. J. Mol. Recognit. 19, 106-180 (2006).
19. Pardeshi, S., Dhodapkar, R. & Kumar, A. Molecularly imprinted microspheres and nanoparticles prepared using precipitation polymerisation method for selective extraction of gallic acid from Emblica officinalis. Food Chem. 146, 385-393 (2014).
20. Gu, J. Y., Zhang, H., Yuan, G., Chen, L. R. & Xu, X. J. Surface-initiated molecularly imprinted polymeric column: In situ synthesis and application for semi-preparative separation by high performance liquid chromatography. J. Chromatogr. A 1218, 8150-8155 (2011).
21. Ranada, M. L., Akbulut, M., Abad, L. & Guven, O. Molecularly imprinted poly(N-vinyl imidazole) based polymers grafted onto nonwoven fabrics for recognition/removal of phloretic acid. Radiat. Phys. Chem. 94, 93-97 (2014).
22. Ozcan, A. A. & Demirli, S. Molecular Imprinted Solid-Phase Extraction System for the Selective Separation of Oleuropein from Olive Leaf. Sep. Sci. Technol. 49, 74-80 (2014).
23. Dai, C. M., Zhang, J., Zhang, Y. L., Zhou, X. F. & Liu, S. G. Application of Molecularly Imprinted Polymers to Selective Removal of Clofibric Acid from Water. PLoS One 8, e78167 (2013).
24. Bakas, I. et al. Molecular imprinting solid phase extraction for selective detection of methidathion in olive oil. Anal. Chim. Acta 734, 99-105 (2012).
25. Xu, X. J., Zhu, L. L. & Chen, L. R. Separation and screening of compounds of biological origin using molecularly imprinted polymers. J. Chromatogr. B 804, 61-69 (2004).
26. Vasapollo, G. et al. Molecularly imprinted polymers: present and future prospective. Int. J. Mol. Sci. 12, 5908-5945 (2011).
27. Ge, Y. & Turner, A. P. F. Molecularly Imprinted Sorbent Assays: Recent Developments and Applications. Chem-Eur J. 15, 8100-8107 (2009).
28. Giovannoli, C., Anfossi, L., Biagioli, F., Passini, C. & Baggiani, C. Solid phase extraction of penicillins from milk by using sacrificial silica beads as a support for a molecular imprint. Microchim. Acta 180, 1371-1377 (2013).
29. Luo, W. et al. Synthesis of surface molecularly imprinted silica micro-particles in aqueous solution and the usage for selective off-line solid-phase extraction of 2,4-dinitrophenol from water matrixes. Anal. Chim. Acta 618, 147-156 (2008).
30. Chen, T. F. et al. Semi-Preparative Scale Separation of Emodin from Plant Extract by Using Molecularly Imprinted Polymer as Stationary Phase. Chromatographia 77, 893-899 (2014).
31. Zhu, T., Li, S. N. & Row, K. H. Molecularly Imprinted Monolithic Material for the Extraction of Three Organic Acids from Salicornia herbacea L. J. Appl. Polym. Sci. 121, 1691-1696 (2011).
32. Michailof, C., Manesiotis, P. & Panayiotou, C. Synthesis of caffeic acid and p-hydroxybenzoic acid molecularly imprinted polymers and their application for the selective extraction of polyphenols from olive mill waste waters. J. Chromatogr. A 1182, 25-33 (2008).
33. Valero-Navarro, A. et al. Synthesis of caffeic acid molecularly imprinted polymer microspheres and high-performance liquid chromatography evaluation of their sorption properties. J. Chromatogr. A 1218, 7289-7296 (2011).
34. Huang, X. M., Liu, Y. J., He, Y. Z., Chen, F. F. & Wang, Y. K. Clinical observation of Reduning injection in treatment of patients with acute upper respiratory tract infections. Chin. J. Clin. Pharmacol. Ther. 11, 470-473 (2006).
35. Zhang, Y. The Clinical Efficacy of Reduning in the Treatment of HFMD. Guide of China Medicine 9, 33-34 (2011).
36. Li, Y. J. et al. Direct analysis in real time ionization/quadrupole time-of-flight tandem mass spectrometry for rapid identification of iridoid glycosides and caffeoylquinic acids in Re Du Ning Injections. Anal. Methods-UK 5, 7081-7089 (2013).
37. Li, H. B. Studies on Pharmacodynamic Material Basis of Reduning Injection Ph.D thesis, Nanjing University of Chinese Medicine (2013).
38. Chou, T. C. & Talalay, P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22, 27-55 (1984).
39. Zhang, X. Z. et al. Network pharmacology study on the mechanism of traditional Chinese medicine for upper respiratory tract infection. Mol. BioSyst. 10, 2517-2525 (2014).
40. Zhang, X. Z. et al. Insights into the inhibition and mechanism of compounds against LPS-induced PGE2 production: a pathway network-based approach and molecular dynamics simulations. Integr. Biol. DOI: 10.1039/C4IB00141A (2014).
41. Zhuang, Y., Luo, H. P., Duan, D. L., Chen, L. R. & Xu, X. J. In situ synthesis of molecularly imprinted polymers on glass microspheres in a column. Anal. Bioanal. Chem. 389, 1177-1183 (2007).
42. Bi, Y. A. et al. The Fingerprint Research and Multi-component Qualitative Analysis of Reduning Injection via HPLC. Mode. Tradit. Chin. Med. Mater. Med 12, 298-303 (2010).
43. Zhang, X. Z. et al. Bauer ketones 23 and 24 from Echinacea paradoxa var. paradoxa inhibit lipopolysaccharide-induced nitric oxide, prostaglandin E2 and cytokines in RAW264.7 mouse macrophages. Phytochemistry 74, 146-158 (2012).
44. Tewtrakul, S., Wattanapiromsakul, C. & Mahabusarakam, W. Effects of compounds from Garcinia mangostana on inflammatory mediators in RAW264.7 macrophage cells. J. Ethnopharmacol. 121, 379-382 (2009).
45. Jin, X. H. et al. Effects of blue honeysuckle (Lonicera caerulea L.) extract on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp. Eye Res. 82, 860-867 (2006).
46. Wagner, H. & Ulrich-Merzenich, G. Synergy research: Approaching a new generation of phytopharmaceuticals. Phytomedicine 16, 97-110 (2009).
47. Urich-Merzenich, G., Panek, D., Zeitler, H., Wagner, H. & Vetter, H. New perspectives for synergy research with the "omic"-technologies. Phytomedicine 16, 495-508 (2009).
48. Hemalswarya, S. & Doble, M. Potential synergism of natural products in the treatment of cancer. Phytother. Res. 20, 239-249 (2006).
49. Williamson, E. M. Synergy and other interactions in phytomedicines. Phytomedicine 8, 401-409 (2001).
50. Chou, T. C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 58, 621-681 (2006).